Liangxian Cao

机构：Pfeiffer Medical Center · ORCID：0000-0002-7979-1612

发表论文 58 篇 · 总被引 1260 次 · h-index 15

代表论文

Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder (2024 · Molecular Therapy · 被引 12)
Data from Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian Cancer (2023)
Supplementary Excel file-1 from Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties (2023)
Supplementary Excel file-1 from Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties (2023)
Figure S1 from Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer (2023)
Data from Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer (2023)